Status:

RECRUITING

Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers

Lead Sponsor:

University of Wisconsin, Madison

Collaborating Sponsors:

National Center for Advancing Translational Sciences (NCATS)

Conditions:

Skin Cancer

Melanoma (Skin Cancer)

Eligibility:

All Genders

18+ years

Brief Summary

The goal of this observational study is to study blood samples and compare them to other biospecimens and clinical outcomes in participants who have melanoma or non-melanoma skin cancers. The main que...

Detailed Description

This observational study is being done to identify possible biomarkers that can be used for prognostic, prediction, or monitoring considerations in patients with melanoma or non-melanoma skin cancer u...

Eligibility Criteria

Inclusion

  • Age ≥18 years.
  • Participants must meet at least one of the following criteria:
  • Finding suspicious of melanoma or non-melanoma skin cancer based on clinical, radiographic, or laboratory findings. Non-melanoma skin cancers include: basal cell carcinoma, cutaneous squamous cell carcinoma, and Merkel cell carcinoma.
  • A confirmed diagnosis of melanoma or non-melanoma skin cancer.

Exclusion

  • Vulnerable populations, including pregnant women, those who lack consent capacity, the mentally ill, prisoners, cognitively impaired persons, children (age \<18), and UW employees that report to the investigator(s) or to study team members.
  • Not suitable for study participation due to other reasons at the discretion of the investigators.

Key Trial Info

Start Date :

December 11 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT06608511

Start Date

December 11 2024

End Date

December 1 2026

Last Update

December 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Wisconsin

Madison, Wisconsin, United States, 53705